Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells - PubMed (original) (raw)

. 2008 Jul;128(7):1691-5.

doi: 10.1038/sj.jid.5701246. Epub 2008 Jan 17.

Affiliations

• PMID: 18200050
• DOI: 10.1038/sj.jid.5701246

Free article

Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells

Marloes S van Kester et al. J Invest Dermatol. 2008 Jul.

Free article

Abstract

Sézary syndrome (Sz) is an aggressive cutaneous CD4(+) T-cell lymphoma with tumor cells (Sz cells) localized in the skin, lymph nodes, and peripheral blood. Using western blotting, we demonstrate the expression of phosphorylated (P)-Stat3 in the Sz-derived cell line Seax, and in freshly isolated tumor cells from Sz patients (n=6). In Vitro overnight culture without exogenous cytokines results in decreased expression of P-Stat3 (n=3), indicating that Stat3 is not constitutively activated. Incubation of the Seax cell line with the Jak/Stat3 inhibitor Cucurbitacin I resulted in a time- and concentration-dependent decrease of P-Stat3 and Stat3. In freshly isolated Sz cells (n=3), Cucurbitacin I induced a concentration-dependent decrease in Stat3 expression whereas P-Stat3 was undetectable. Finally, incubation of freshly isolated Sz cells (n=4) with 30 microM Cucurbitacin I for 6 hours induced apoptosis in the large majority (73-91%) of tumor cells. These data strengthen the notion that activation of Stat3 plays an essential part in the malignant transformation of Sz and provide further rationale for the therapeutical targeting of Stat3 in Sz.

PubMed Disclaimer

Similar articles

• Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
  Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Eriksen KW, et al. Leukemia. 2001 May;15(5):787-93. doi: 10.1038/sj.leu.2402093. Leukemia. 2001. PMID: 11368440
• Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome.
  van der Fits L, Out-Luiting JJ, Tensen CP, Zoutman WH, Vermeer MH. van der Fits L, et al. J Invest Dermatol. 2014 Oct;134(10):2639-2647. doi: 10.1038/jid.2014.199. Epub 2014 Apr 22. J Invest Dermatol. 2014. PMID: 24756111
• Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells.
  Brouwer IJ, Out-Luiting JJ, Vermeer MH, Tensen CP. Brouwer IJ, et al. Biochem Biophys Rep. 2020 Oct 15;24:100832. doi: 10.1016/j.bbrep.2020.100832. eCollection 2020 Dec. Biochem Biophys Rep. 2020. PMID: 33102814 Free PMC article.
• MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
  van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH, Willemze R, Tensen CP, Vermeer MH. van der Fits L, et al. J Invest Dermatol. 2011 Mar;131(3):762-8. doi: 10.1038/jid.2010.349. Epub 2010 Nov 18. J Invest Dermatol. 2011. PMID: 21085192
• [The Sézary syndrome].
  Ferreira F, Correia TM, Callabro L, Andrade J. Ferreira F, et al. Acta Med Port. 1998 Dec;11(12):1135-9. Acta Med Port. 1998. PMID: 10192992 Review. Portuguese.

Cited by

• Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma.
  Lin M, Kowolik CM, Xie J, Yadav S, Overman LE, Horne DA. Lin M, et al. Cancers (Basel). 2021 Jul 5;13(13):3367. doi: 10.3390/cancers13133367. Cancers (Basel). 2021. PMID: 34282785 Free PMC article.
• Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
  García-Colmenero L, González J, Sandoval J, Guillén Y, Diaz-Lagares A, Andrades E, Iglesias A, Nonell L, Pujol RM, Bigas A, Espinosa L, Gallardo F. García-Colmenero L, et al. Cells. 2020 Dec 15;9(12):2692. doi: 10.3390/cells9122692. Cells. 2020. PMID: 33333886 Free PMC article.
• Cucurbitacin I inhibits cell motility by indirectly interfering with actin dynamics.
  Knecht DA, LaFleur RA, Kahsai AW, Argueta CE, Beshir AB, Fenteany G. Knecht DA, et al. PLoS One. 2010 Nov 24;5(11):e14039. doi: 10.1371/journal.pone.0014039. PLoS One. 2010. PMID: 21124831 Free PMC article.
• Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
  Netchiporouk E, Litvinov IV, Moreau L, Gilbert M, Sasseville D, Duvic M. Netchiporouk E, et al. Cell Cycle. 2014;13(21):3331-5. doi: 10.4161/15384101.2014.965061. Cell Cycle. 2014. PMID: 25485578 Free PMC article.
• ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.
  Ni X, Zhang X, Hu CH, Langridge T, Tarapore RS, Allen JE, Oster W, Duvic M. Ni X, et al. Oncotarget. 2017 Jun 27;8(37):61761-61776. doi: 10.18632/oncotarget.18688. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977902 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal